Efficacy of Favipiravir Against Ebola (JIKI)

NCT02329054 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

126

Enrollment

OTHER_GOV

Sponsor class

Conditions

Ebola Virus Disease

Interventions

DRUG: Favipiravir

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France